AVE7688 in Patients With Mild to Moderate Blood Pressure
Status:
Completed
Trial end date:
2008-03-01
Target enrollment:
Participant gender:
Summary
The primary objective is to assess the antihypertensive efficacy of 4 different AVE 7688
doses on the change from baseline in trough diastolic blood pressure at the end of week 12.
The secondary objectives are:
- To assess the antihypertensive efficacy of 4 different AVE 7688 doses on the change from
baseline in trough systolic blood pressure at the end of week 12
- To compare the percentages of responders after 12 week of treatment
- To evaluate the long term safety and tolerability of AVE 7688 with particular attention
to angioedema